| 前收市價 | 536.17 |
| 開市 | 538.65 |
| 買盤 | 532.60 x 800 |
| 賣出價 | 532.91 x 800 |
| 今日波幅 | 532.30 - 538.86 |
| 52 週波幅 | 412.00 - 542.07 |
| 成交量 | |
| 平均成交量 | 971,408 |
| 市值 | 123.809B |
| Beta 值 (5 年，每月) | 0.81 |
| 市盈率 (最近 12 個月) | 20.11 |
| 每股盈利 (最近 12 個月) | 26.49 |
| 業績公佈日 | 2024年7月17日 - 2024年7月22日 |
| 遠期股息及收益率 | 6.52 (1.22%) |
| 除息日 | 2024年6月10日 |
| 1 年預測目標價 | 605.45 |
ZacksIs Elevance Health (ELV) a Buy as Wall Street Analysts Look Optimistic?
Based on the average brokerage recommendation (ABR), Elevance Health (ELV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ZacksIf You Invested $1000 in Elevance Health a Decade Ago, This is How Much It'd Be Worth Now
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
ZacksHCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions
HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.
